Oxford University Press (OUP) is pleased to announce its partnership with BGI. Beginning January 2017, Oxford University Press (OUP) is the proud publisher of the prestigious, open-access, open-data journal, GigaScience. The journal has an international and multidisciplinary editorial board led by Laurie Goodman Ph.D. as Editor-in-Chief and Scott Edmunds Ph.D. as Executive Editor.
An innovative, new, patient-driven natural history registry for the rare and poorly understood immune system disorder Castleman disease (CD) will propel care and research for CD through a collaborative research agreement between Janssen Research & Development, LLC; the Castleman Disease Collaborative Network (CDCN); and the University of Pennsylvania.
The Allen Institute for Brain Science has completed the three-dimensional mapping of the mouse cortex as part of the Allen Mouse Common Coordinate Framework (CCF): a standardized spatial coordinate system for comparing many types of data on the brain from the suite of Allen Brain Atlas resources.
The Science and Science Careers' 2016 annual Top Employers Survey polled employees in the biotechnology, biopharmaceutical, pharmaceutical, and related industries to determine the 20 best employers in these industries as well as their driving characteristics. Respondents to the web-based survey were asked to rate companies based on 23 characteristics, including financial strength, easy adaptation to change, and a research-driven environment.
The University of Texas MD Anderson Cancer Center's Institute for Applied Cancer Science (IACS) has initiated the first clinical study of a novel drug designed to starve cancer cells, IACS-10759.
Dartmouth researchers, led by Christopher Amos, PhD, Dartmouth Professor and Interim Director of Norris Cotton Cancer Center, formed a consortium of multiple institutions, funded by many sources. The consortium has developed approaches for quality control of SNP selection, site selection, and genotyping and ancestry analysis accuracy in order to understand causes of common cancers including genetic and environmental, and their interactions. Details of the consortium's goal and purpose were recently published in Cancer Epidemiology Biomarkers.
A NASA-developed tool that private industry and other agency centers now use to plot a mission's path to far-flung interplanetary destinations has gotten significantly more proficient and can now even reveal -- sometimes in just a matter of minutes -- the specifics of the spacecraft's mission and elements of the system design.
The Circadian Rhythms investigation examines whether long-term spaceflight throws off circadian rhythm in astronauts and the role of factors such as irregular light and dark cycles, microgravity induced changes in body composition, and reduced physical activity.
The American Cancer Society in collaboration with the National Cancer Institute has launched an online tool for cancer survivors.
Insilico Medicine Inc. will present its most recent advances in applying the deep learning techniques to biomarker development and drug discovery at the GPU Technology Conference Washington, D.C.